Signaturefd LLC Has $833,000 Stake in The Clorox Company (NYSE:CLX)

Signaturefd LLC grew its stake in shares of The Clorox Company (NYSE:CLX) by 7.4% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 5,840 shares of the company’s stock after buying an additional 404 shares during the period. Signaturefd LLC’s holdings in Clorox were worth $833,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in the stock. International Assets Investment Management LLC raised its stake in shares of Clorox by 17,658.5% in the fourth quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock valued at $69,078,000 after purchasing an additional 481,725 shares in the last quarter. Adage Capital Partners GP L.L.C. bought a new stake in Clorox during the third quarter worth about $6,605,000. Eagle Rock Investment Company LLC bought a new stake in Clorox during the fourth quarter worth about $2,940,000. Nordea Investment Management AB increased its holdings in shares of Clorox by 4.0% during the fourth quarter. Nordea Investment Management AB now owns 9,551 shares of the company’s stock worth $1,362,000 after buying an additional 364 shares in the last quarter. Finally, Teacher Retirement System of Texas boosted its holdings in shares of Clorox by 742.8% in the 3rd quarter. Teacher Retirement System of Texas now owns 78,713 shares of the company’s stock worth $10,316,000 after acquiring an additional 69,373 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Stock Up 1.1 %

Clorox stock opened at $145.19 on Tuesday. The Clorox Company has a fifty-two week low of $114.68 and a fifty-two week high of $178.21. The company has a debt-to-equity ratio of 11.37, a current ratio of 0.89 and a quick ratio of 0.57. The firm has a market capitalization of $18.02 billion, a price-to-earnings ratio of 230.46, a PEG ratio of 2.27 and a beta of 0.43. The company’s 50 day simple moving average is $149.82 and its 200 day simple moving average is $142.09.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Thursday, February 1st. The company reported $2.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.08 by $1.08. The company had revenue of $1.99 billion during the quarter, compared to analyst estimates of $1.80 billion. Clorox had a net margin of 1.09% and a return on equity of 319.41%. The firm’s revenue was up 16.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.98 EPS. As a group, sell-side analysts anticipate that The Clorox Company will post 5.52 EPS for the current year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Wednesday, April 24th will be given a dividend of $1.20 per share. This represents a $4.80 dividend on an annualized basis and a dividend yield of 3.31%. The ex-dividend date is Tuesday, April 23rd. Clorox’s dividend payout ratio is currently 761.92%.

Wall Street Analysts Forecast Growth

CLX has been the subject of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft dropped their price target on Clorox from $155.00 to $151.00 and set a “hold” rating for the company in a report on Wednesday, April 17th. Jefferies Financial Group raised Clorox from an “underperform” rating to a “hold” rating and set a $145.00 price target for the company in a report on Tuesday, March 26th. Citigroup decreased their price objective on shares of Clorox from $165.00 to $155.00 and set a “neutral” rating on the stock in a report on Tuesday, April 16th. JPMorgan Chase & Co. upped their target price on shares of Clorox from $145.00 to $152.00 and gave the stock a “neutral” rating in a research report on Thursday, January 18th. Finally, Barclays lowered their target price on Clorox from $148.00 to $136.00 and set an “underweight” rating for the company in a research note on Wednesday, April 10th. Four research analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $148.63.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.